IndicationsStatusPurposePhase
Active Not RecruitingOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT02649686Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab